These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9242439)

  • 1. Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene.
    Wallrapp C; Müller-Pillasch F; Solinas-Toldo S; Lichter P; Friess H; Büchler M; Fink T; Adler G; Gress TM
    Cancer Res; 1997 Aug; 57(15):3135-9. PubMed ID: 9242439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
    Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
    Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYB oncogene amplification in hereditary BRCA1 breast cancer.
    Kauraniemi P; Hedenfalk I; Persson K; Duggan DJ; Tanner M; Johannsson O; Olsson H; Trent JM; Isola J; Borg A
    Cancer Res; 2000 Oct; 60(19):5323-8. PubMed ID: 11034064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer.
    Laurila E; Savinainen K; Kuuselo R; Karhu R; Kallioniemi A
    Genes Chromosomes Cancer; 2009 Apr; 48(4):330-9. PubMed ID: 19145645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale molecular mapping of human c-myb locus: c-myb proto-oncogene is not involved in 6q- abnormalities of lymphoid tumors.
    Park JG; Reddy EP
    Oncogene; 1992 Aug; 7(8):1603-9. PubMed ID: 1630821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.
    Kuuselo R; Savinainen K; Azorsa DO; Basu GD; Karhu R; Tuzmen S; Mousses S; Kallioniemi A
    Cancer Res; 2007 Mar; 67(5):1943-9. PubMed ID: 17332321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
    Tantravahi R; Dudek H; Patel G; Reddy EP
    Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer.
    Mahlamäki EH; Bärlund M; Tanner M; Gorunova L; Höglund M; Karhu R; Kallioniemi A
    Genes Chromosomes Cancer; 2002 Dec; 35(4):353-8. PubMed ID: 12378529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines.
    Tang TC; Sham JS; Xie D; Fang Y; Huo KK; Wu QL; Guan XY
    Cancer Res; 2002 Dec; 62(24):7157-61. PubMed ID: 12499249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer.
    Miwa W; Yasuda J; Murakami Y; Yashima K; Sugano K; Sekine T; Kono A; Egawa S; Yamaguchi K; Hayashizaki Y; Sekiya T
    Biochem Biophys Res Commun; 1996 Aug; 225(3):968-74. PubMed ID: 8780719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
    Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The erbB-3 gene in human pancreatic cancer.
    Lemoine NR; Lobresco M; Leung H; Barton C; Hughes CM; Prigent SA; Gullick WJ; Klöppel G
    J Pathol; 1992 Nov; 168(3):269-73. PubMed ID: 1361525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance.
    Schleger C; Verbeke C; Hildenbrand R; Zentgraf H; Bleyl U
    Mod Pathol; 2002 Apr; 15(4):462-9. PubMed ID: 11950922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific methylation patterns of erbB2 (HER2/neu) sequences in gastro-intestinal cancer.
    Holzmann K; Welter C; Klein V; Pistorius G; Seitz G; Blin N
    Anticancer Res; 1992; 12(3):1013-8. PubMed ID: 1352439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.
    Yokota J; Yamamoto T; Miyajima N; Toyoshima K; Nomura N; Sakamoto H; Yoshida T; Terada M; Sugimura T
    Oncogene; 1988 Mar; 2(3):283-7. PubMed ID: 3281095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of genomically amplified segments using PCR: optimizing relative-PCR for reliable and simple gene expression and gene copy analyses.
    Jonson T; Mahlamäki EH; Karhu R; Gorunova L; Johansson B; Höglund M
    Genes Chromosomes Cancer; 2000 Oct; 29(2):192-9. PubMed ID: 10959100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences.
    Vellard M; Soret J; Viegas-Pequignot E; Galibert F; Nguyen VC; Dutrillaux B; Perbal B
    Oncogene; 1991 Apr; 6(4):505-14. PubMed ID: 1840680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of C-myb genetic alterations and mutant p53 serum protein in patients with benign and malignant colon lesions.
    Greco C; Gandolfo GM; Mattei F; Gradilone A; Alvino S; Pastore LI; Casale V; Casole P; Grassi A; Cianciulli AM
    Anticancer Res; 1994; 14(3B):1433-40. PubMed ID: 8067719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas.
    Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G
    Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.